Plant Advanced Technologies SA (EPA:ALPAT)
France · Delayed Price · Currency is EUR 3.900
-0.340 (-8.02%)
Oct 2, 2026, 2:09 PM CET
EPA:ALPAT Revenue
In the year 2025, Plant Advanced Technologies had annual revenue of 1.37M EUR, down -29.06%.
Revenue
1.37M
Revenue Growth
-29.06%
P/S Ratio
3.20
Revenue / Employee
124.61K
Employees
11
Market Cap
4.38M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.37M | -561.38K | -29.06% |
| Dec 31, 2024 | 1.93M | 250.60K | 14.90% |
| Dec 31, 2023 | 1.68M | -657.49K | -28.11% |
| Dec 31, 2022 | 2.34M | 34.00K | 1.48% |
| Dec 31, 2021 | 2.31M | 586.00K | 34.09% |
| Dec 31, 2020 | 1.72M | 546.19K | 46.57% |
| Dec 31, 2019 | 1.17M | 31.03K | 2.72% |
| Dec 31, 2018 | 1.14M | 335.01K | 41.52% |
| Dec 31, 2017 | 806.78K | -347.22K | -30.09% |
| Dec 31, 2016 | 1.15M | 141.00K | 13.92% |
| Dec 31, 2015 | 1.01M | 111.12K | 12.32% |
| Dec 31, 2014 | 901.88K | -304.62K | -25.25% |
| Dec 31, 2013 | 1.21M | 289.50K | 31.57% |
| Dec 31, 2012 | 917.00K | 703.09K | 328.68% |
| Dec 31, 2011 | 213.91K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Poxel | 7.66M |
| Advicenne | 6.50M |
| MaaT Pharma | 3.18M |
| Aelis Farma | 2.19M |
| Oncodesign Precision Medicine Société anonyme | 1.81M |
| Aton | 661.00K |
| TME Pharma | 27.00K |
| NFL Biosciences | 188.00 |